Position in TECH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$919,933
-$360,959 QoQ
Shares Held
13,021
-46.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#291
of 588 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $12,227,346 across 14 Biotechnology names. TECH ranks #3 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,927 | $5,427,768 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
24,401 | $1,909,866 | |
| 3 | TECH |
BIO-TECHNE Corp
This page
|
13,021 | $919,933 | |
| 4 | CYTK |
Cytokinetics Inc
|
9,887 | $842,273 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
11,380 | $651,163 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
33,083 | $594,501 | |
| 7 | MRNA |
Moderna, Inc.
|
6,604 | $462,478 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
1,152 | $428,163 |
All Filings in TECH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $919,933 | 13,021 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,280,892 | 24,510 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,490,304 | 25,341 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $951,551 | 17,105 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $892,606 | 17,349 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,441,594 | 24,588 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,863,624 | 39,756 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||